ALPS Advisors’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-491,610
Closed -$590K 990
2024
Q1
$590K Sell
491,610
-44,871
-8% -$44.9K ﹤0.01% 573
2023
Q4
$810K Buy
+536,481
New +$776K 0.01% 527
2023
Q2
Sell
-509,055
Closed -$743K 1023
2023
Q1
$743K Sell
509,055
-15,537
-3% -$20K 0.01% 524
2022
Q4
$656K Buy
524,592
+103,188
+24% +$163K 0.01% 541
2022
Q3
$796K Buy
421,404
+16,862
+4% +$39.9K 0.01% 513
2022
Q2
$1.02M Sell
404,542
-295,826
-42% -$863K 0.01% 471
2022
Q1
$2.41M Sell
700,368
-88,162
-11% -$311K 0.03% 183
2021
Q4
$3.79M Buy
+788,530
New +$3.19M 0.04% 166
2017
Q4
Sell
-550,909
Closed -$3.78M 872
2017
Q3
$3.78M Buy
550,909
+45,985
+9% +$290K 0.03% 154
2017
Q2
$3.32M Buy
504,924
+491,593
+3,688% +$3.45M 0.02% 158
2017
Q1
$107K Buy
13,331
+3,312
+33% +$27.9K ﹤0.01% 719
2016
Q4
$93K Sell
10,019
-4,176
-29% -$43.2K ﹤0.01% 710
2016
Q3
$150K Sell
14,195
-2,806
-17% -$27.9K ﹤0.01% 666
2016
Q2
$159K Buy
+17,001
New +$173K ﹤0.01% 602

Other funds holding OPK

ALPS Advisors's OPK Position: Q2 2024 in Review

ALPS Advisors sold out of Opko Health (OPK) in Q2 2024, closing a stake of 491,610 shares — an estimated $590K sold.

ALPS Advisors first reported a position in OPK in Q2 2016 and held it in 14 quarters. The position peaked at $3.79M in Q4 2021. 232 funds tracked by Wall St. Rank hold OPK as of Q2 2024.

  • ALPS Advisors reported no remaining Opko Health position as of Q2 2024 after selling out during the quarter.
  • ALPS Advisors sold 491,610 Opko Health shares in Q2 2024, an estimated $590K.
  • ALPS Advisors first reported a position in Opko Health in Q2 2016 and held it in 14 quarters.
  • ALPS Advisors's Opko Health position peaked at $3.79M in Q4 2021.
  • 232 funds tracked by Wall St. Rank held Opko Health as of Q2 2024.

Based on ALPS Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.